Viewing Study NCT00617305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT00617305
Status: COMPLETED
Last Update Posted: 2012-07-30
First Post: 2008-02-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Arterial Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ambrisentan View
None PAH View
None combination therapy View
None phosphodiesterase type-5 inhibitor (PDE-5i) View
None cardiovascular View
None endothelin receptor antagonist View
None ERA View